The anti-angiogenic activities of glycyrrhizic acid in tumor progression

Phytotherapy Research

Volumn 27, Issue 6, 2013, Pages 841-846

  Kim, Kil Jung ^a,b   Choi, Jae Sun ^a,b   Kim, Kyu Won ^c,d   Jeong, Joo Won ^a,b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

angiogenesis; anti oxidant; cancer prevention; glycyrrhizic acid

Indexed keywords

GLYCYRRHIZIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVATION; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCYRRHIZIC ACID; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

GLYCYRRHIZA; MUS;

EID: 84878822151     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4800     Document Type: Article

References (48)

1. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L,. 2003. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63 (7): 1684-1695.
2. Akamatsu H, Komura J, Asada Y, Niwa Y,. 1991. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med 57 (2): 119-121.
3. Bussolino F, Di Renzo MF, Ziche M, et al,. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119 (3): 629-641.
4. Carmeliet P, Jain RK,. 2000. Angiogenesis in cancer and other diseases. Nature 407 (6801): 249-257.
5. Chung BH, Kim JD, Kim CK, et al,. 2008. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun 376 (2): 404-408.
6. Dai J, Peng L, Fan K, et al,. 2009. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28 (38): 3412-3422.
7. Fidler IJ,. 2000. Angiogenesis and cancer metastasis. Cancer J 6 (Suppl 2): S134-141.
8. Gerald D, Berra E, Frapart YM, et al,. 2004. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (6): 781-794.
9. Grant DS, Kleinman HK, Goldberg ID, et al,. 1993. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90 (5): 1937-1941.
10. Gu H, Gong L, Yu J,. 2002. Measurement and comparison of glycyrrhizic acid contents in root of licorice (Glycyrrhiza uralensis Fisch.) from different cultivating areas. J Forestry Res 13 (2): 141-143.
11. Gwak GY, Moon TG, Lee DH, Yoo BC,. 2012. Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastroenterol 18 (7): 679-684.
12. Hibasami H, Iwase H, Yoshioka K, Takahashi H,. 2005. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int J Mol Med 16 (2): 233-236.
13. Hibasami H, Iwase H, Yoshioka K, Takahashi H,. 2006. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int J Mol Med 17 (2): 215-219.
14. Hu Y, Wang X, Zeng L, et al,. 2005. ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell 16 (8): 3705-3718.
15. Jiang BH, Liu LZ,. 2009. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102: 19-65.
16. Kao TC, Shyu MH, Yen GC,. 2009. Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway. J Agric Food Chem 57 (2): 754-761.
17. Kerbel R, Folkman J,. 2002. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2 (10): 727-739.
18. Kim JH, Park SY, Kim HJ,. 2006. The Effect of Combination Therapy with Radiation and Selective Cyclooxygenase-1 Inhibitor on Xenografted Human Oral Cavity Squamous Cell Carcinoma in Nude Mice. Korean J Otolaryngol 49: 420-425.
19. Kobayashi I, Semba S, Matsuda Y, Kuroda Y, Yokozaki H,. 2006. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma. Pathobiology 73 (1): 8-17.
20. Lamy S, Lachambre MP, Lord-Dufour S, Beliveau R,. 2010. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vascul Pharmacol 53 (5-6): 200-208.
21. Luczak K, Balcerczyk A, Soszynski M, Bartosz G,. 2004. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 28 (6): 483-486.
22. Markowska AI, Liu FT, Panjwani N,. 2010. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med 207 (9): 1981-1993.
23. McCubrey JA, Steelman LS, Abrams SL, et al,. 2006. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 46: 249-279.
24. Munoz-Chapuli R, Quesada AR, Angel MM,. 2004. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61 (17): 2224-2243.
25. Nakagami H, Morishita R, Yamamoto K, et al,. 2001. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37 (2 Part 2): 581-586.
26. Nishino H, Kitagawa K, Iwashima A,. 1984. Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7,12-dimethylbenz[a] anthracene plus teleocidin. Carcinogenesis 5 (11): 1529-1530.
27. Park HJ, Kim SR, Bae SK, et al,. 2009. Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells. Exp Cell Res 315 (19): 3359-3369.
28. Poon RT, Fan ST, Wong J,. 2001. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19 (4): 1207-1225.
29. Rahman S, Sultana S,. 2006. Chemopreventive activity of glycyrrhizin on lead acetate mediated hepatic oxidative stress and its hyperproliferative activity in Wistar rats. Chem Biol Interact 160 (1): 61-69.
30. Rahman S, Sultana S,. 2007. Glycyrrhizin exhibits potential chemopreventive activity on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in Swiss albino mice. J Enzyme Inhib Med Chem 22 (3): 363-369.
31. Sato H, Goto W, Yamamura J, et al,. 1996. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res 30 (2-3): 171-177.
32. Shiojima I, Walsh K,. 2002. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90 (12): 1243-1250.
33. Shiota G, Harada K, Ishida M, et al,. 1999. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. Carcinogenesis 20 (1): 59-63.
34. Shono T, Ono M, Izumi H, et al,. 1996. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16 (8): 4231-4239.
35. Tamir S, Eizenberg M, Somjen D, et al,. 2000. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 60 (20): 5704-5709.
36. Thirugnanam S, Xu L, Ramaswamy K, Gnanasekar M,. 2008. Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncol Rep 20 (6): 1387-1392.
37. Ushio-Fukai M, Alexander RW,. 2004. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264 (1-2): 85-97.
38. Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG, Natarajan V,. 1999. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol 277 (1 Pt 1): L150-158.
39. Wang X, Liu JZ, Hu JX, et al,. 2011. ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radic Biol Med 51 (2): 539-551.
40. Wang YD, Hu Y, Zhang L, Sun CY,. 2008. Brain derived neurotrophic factor induces endothelial cells angiogenesis through AKT and ERK1/2 signal pathway. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16 (1): 175-180.
41. Weidner N, Semple JP, Welch WR, Folkman J,. 1991. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324 (1): 1-8.
42. Wu HW, Li HF, Wu XY, Zhao J, Guo J,. 2008. Reactive oxygen species mediate ERK activation through different Raf-1-dependent signaling pathways following cerebral ischemia. Neurosci Lett 432 (2): 83-87.
43. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH,. 2007. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67 (22): 10823-10830.
44. Xu ZL, Guo JH, Song ST, Li MJ, Wu DZ,. 1993. The effect of zinc glycyrrhizate on toxicity and anticancer activity of cisplatin in mice. Yao Xue Xue Bao 28 (8): 567-571.
45. Yang JY, Zong CS, Xia W, et al,. 2008. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10 (2): 138-148.
46. Yasuda M, Ohzeki Y, Shimizu S, et al,. 1999. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64 (4): 249-258.
47. Yi EY, Park SY, Song HS, et al,. 2006. KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis. Exp Mol Med 38 (5): 502-508.
48. Yim SB, Park SE, Lee CS,. 2007. Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J Pharmacol Exp Ther 321 (2): 816-822.